AUSTIN, Texas, July 19, 2021 / PRNewswire / – 154 Agency LLC (154) announced today that it has entered into an agreement with Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (Novo), to perform digital marketing, brand awareness and related work.
154 provides social media, creative strategy, public relations and content marketing. 154 provides its signature digital overhaul for Novo Integrated Sciences and its subsidiaries.
âNovo has a story that needs to be released to the public. Their mission to decentralize the delivery of primary health care, through the integration of medical technology, advanced therapies and rehabilitation science, needs to be told. are extremely excited to expand our portfolio and further develop personalized marketing strategies for a wider range of clients. ” declared Johanna viscaino, CEO of 154. “Our past success in working with other companies will create tremendous value for Novo.”
154’s team is made up of digital marketers who focus their skills on custom branding, brand awareness, custom design, UX consulting, and video production for public companies that require dual awareness to their clients and the investing public.
154 customers include healthcare, education and life sciences companies.
About Novo Integrated Sciences, Inc.
Novo Integrated Sciences, Inc. has Canadian and U.S. subsidiaries that provide, or intend to provide, multidisciplinary primary health care services and products through the integration of medical technology, advanced therapies and the science of rehabilitation. Our clinicians and practitioners are not licensed to practice primary care medicine, and they are not medically licensed to prescribe pharmaceutical solutions.
We believe that the âdecentralizationâ of healthcare, through the integration of medical technology and interconnectivity, offers a key solution to the fundamental transformation of healthcare delivery. Specific to non-critical care, continuous advances in medical technology and interconnectivity allow a shift of the patient / practitioner relationship to the patient’s home and away from on-site visits to primary medical centers with mass services. This acceleration of the “ease of access” in the patient / practitioner interaction for the diagnosis of non-critical care and subsequent treatment minimizes the degradation of non-critical health conditions to critical conditions while allowing more health care delivery. profitable.
Novo’s decentralized healthcare business model centers around three main pillars to best support the transformation of non-catastrophic healthcare delivery to patients and consumers. The first pillar is to lay the foundation for traditional health care delivery, through small and small clinical facilities, within a large service delivery network. The second pillar is the development, integration and deployment of sophisticated technologies, through interconnectivity, which extends the reach of healthcare-related services, beyond the location of the traditional clinic, to geographic areas which do not easily provide advanced health services to date, including the patient’s home. The third pillar is the development and distribution of effective wellness product solutions enabling the personalization of preventive remedies for patients and ultimately a healthier population. Additionally, Novo’s scientific approach to product innovation further emphasizes Novo’s mandate to create and deliver over-the-counter maintenance and prevention solutions. Scientific innovation represented by proprietary technology ensures Novo continuous cutting-edge advancements in patient platforms.
About 154 Agence LLC:
154 Agency LLC is a strategic digital media consulting firm. She specializes in brand development, customer outreach, social media management, social media advertising and Google advertising, investor outreach, e-commerce marketing, customer acquisition, video production and SEO optimization. Its clients are mainly from the education and health sectors. For more information visit www.154agency.com.
SOURCE 154 LLC Agency